867166-09-4 Usage
General Description
8-chloro-3-cyclobutylimidazo[1,5-a]pyrazine is a chemical compound with the molecular formula C9H10ClN3. It is a heterocyclic compound containing a chlorine atom and a cyclobutyl group. 8-chloro-3-cyclobutylimidazo[1,5-a]pyrazine has potential applications in the pharmaceutical industry, specifically in the development of new drugs and pharmaceutical products. Its unique structure and properties make it a promising candidate for further research and development. However, as with any chemical compound, proper safety precautions should be taken when handling and using 8-chloro-3-cyclobutylimidazo[1,5-a]pyrazine. Its potential uses and safety concerns make it an interesting compound for further study and exploration.
Check Digit Verification of cas no
The CAS Registry Mumber 867166-09-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,1,6 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 867166-09:
(8*8)+(7*6)+(6*7)+(5*1)+(4*6)+(3*6)+(2*0)+(1*9)=204
204 % 10 = 4
So 867166-09-4 is a valid CAS Registry Number.
867166-09-4Relevant articles and documents
Fused bicyclic mTOR inhibitors
-
Page/Page column 53, (2008/06/13)
Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS
-
Page/Page column 432, (2008/06/13)
Compounds of the formula (I) and pharmaceutically acceptable salts thereof, wherein XI, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
